Wat is de prijs voor Roche Holding AG (RO)

Het prijs van Roche Holding AG (RO) is $481.73

Wat is de marktkapitalisatie voor Roche Holding AG (RO)

Marktkapitalisatie voorRoche Holding AG (RO) is $377.65B

Roche Holding AG (RO) Dividendrendement

Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.

Jaar	Dividendrendement	Wijzigen
Niet genoeg gegevens voor de verstrekte datums.

Jaar

Dividendrendement

Wijzigen

Niet genoeg gegevens voor de verstrekte datums.

Bedrijf	Dividendrendement	Land
Eli Lilly and Company LLY.US	0.56%	US
Johnson & Johnson JNJ.US	2.04%	US
AbbVie Inc. ABBV.US	2.72%	US
Merck & Co., Inc. MRK.US	2.58%	US
Novartis AG NOVN.SW	2.80%	CH

Bedrijf

Dividendrendement

Land

Eli Lilly and Company

LLY.US

0.56%

Johnson & Johnson

JNJ.US

2.04%

AbbVie Inc.

ABBV.US

2.72%

Merck & Co., Inc.

MRK.US

2.58%

Novartis AG

NOVN.SW

2.80%

Roche Holding AG

RO

Categorie